Validity of Montreal Cognitive Assessment in Non-English speaking patients with Parkinson's disease
dc.contributor.author | Krishnan, S | |
dc.contributor.author | Justus, S | |
dc.contributor.author | Meluveettil, R | |
dc.contributor.author | Menon, RN | |
dc.contributor.author | Sarma, SP | |
dc.contributor.author | Kishore, A | |
dc.date.accessioned | 2017-03-10T03:29:13Z | |
dc.date.available | 2017-03-10T03:29:13Z | |
dc.date.issued | 2015 | |
dc.description.abstract | Background: The Montreal Cognitive Assessment is a brief and easy screening tool for accurately testing cognitive dysfunction in Parkinson's disease. We tested its validity for use in non-English (Malayalam) speaking patients with Parkinson's disease. Materials and Methods: We developed a Malayalam (a south-Indian language) version of Montreal Cognitive Assessment and applied to 70 patients with Parkinson's disease and 60 age-and education-matched healthy controls. Metric properties were assessed, and the scores were compared with the performance in validated Malayalam versions of Mini Mental Status Examination and Addenbrooke's Cognitive Examination. Results: The Montreal Cognitive Assessment-Malayalam showed good internal consistency and test-retest reliability and its scores correlated with Mini Mental Status Examination (patients: R = 0.70; P < 0.001; healthy controls: R = 0.26; P = 0.04) and Addenbrooke's Cognitive Examination (patients: R = 0.8; P < 0.001; healthy controls: R = 0.52; P < 0.001) scores. Conclusion: This study establishes the reliability of cross-cultural adaptation of Montreal Cognitive Assessment for assessing cognition in Malayalam-speaking Parkinson's disease patients for early screening and potential future interventions for cognitive dysfunction. | |
dc.identifier.citation | 63 ,1;63-67 | en_US |
dc.identifier.uri | 10.4103/0028-3886.152637 | |
dc.identifier.uri | https://dspace.sctimst.ac.in/handle/123456789/10675 | |
dc.publisher | NEUROLOGY INDIA | |
dc.subject | Neurosciences & Neurology | |
dc.title | Validity of Montreal Cognitive Assessment in Non-English speaking patients with Parkinson's disease |